Sell 9/23/2019Downgrade
Invictus MD Strategies Corp. (IVITF) was downgraded to D- from D on 9/23/2019 due to a substantial decline in the total return index, volatility index and efficiency index. Total capital declined 3.53% from $99.53M to $96.03M.

Sell 12/18/2018Downgrade
Invictus MD Strategies Corp. (IVITF) was downgraded to D from D+ on 12/18/2018 due to a large decline in the total return index and volatility index.

Sell 12/3/2018Upgraded
Invictus MD Strategies Corp. (IVITF) was upgraded to D+ from D on 12/3/2018 due to a noticeable increase in the total return index and valuation index.

Sell 7/10/2018Downgrade
Invictus MD Strategies Corp. (IVITF) was downgraded to D from D+ on 7/10/2018 due to a decline in the total return index.

Sell 6/22/2018Upgraded
Invictus MD Strategies Corp. (IVITF) was upgraded to D+ from D on 6/22/2018 due to a noticeable increase in the efficiency index, growth index and solvency index. Total revenue increased 89.41% from $539.2 to $1.02M, and EBIT increased 50.2% from -$4.58M to -$2.28M.

Sell 4/25/2018Downgrade
Invictus MD Strategies Corp. (IVITF) was downgraded to D from D+ on 4/25/2018 due to a decline in the total return index, efficiency index and solvency index. Net income declined 337.54% from -$2.25M to -$9.85M, and total capital declined 14.67% from $73.78M to $62.96M.

Sell 12/7/2017Upgraded
Invictus MD Strategies Corp. (IVITF) was upgraded to D+ from D on 12/7/2017 due to a large increase in the total return index, efficiency index and growth index. Earnings per share increased from -$0.1789 to -$0.0301, net income increased 66.14% from -$6.65M to -$2.25M, and EBIT increased 60.24% from -$4.59M to -$1.83M.

Sell 6/1/2017Downgrade
Invictus MD Strategies Corp. (IVITF) was downgraded to D from D+ on 6/1/2017 due to a significant decline in the valuation index, growth index and efficiency index. EBIT declined 556.42% from -$442.9 to -$2.91M, net income declined 481.75% from -$461.3 to -$2.68M, and operating cash flow declined 362.38% from $582.2 to -$1.53M.

Sell 5/10/2017Downgrade
Invictus MD Strategies Corp. (IVITF) was downgraded to D+ from C- on 5/10/2017 due to a decline in the total return index.

Hold 4/17/2017Upgraded
Invictus MD Strategies Corp. (IVITF) was upgraded to C- from D+ on 4/17/2017 due to a noticeable increase in the total return index, volatility index and growth index.

Sell 12/30/2016Upgraded
Invictus MD Strategies Corp. (IVITF) was upgraded to D+ from D on 12/30/2016 due to a significant increase in the total return index, growth index and dividend index. Operating cash flow increased 236.87% from -$426.4 to $583.6, earnings per share increased from -$0.1432 to -$0.0481, and EBIT increased 18.61% from -$545.4 to -$443.9.

Sell 10/25/2016Upgraded
Invictus MD Strategies Corp. (IVITF) was upgraded to D from D- on 10/25/2016 due to a noticeable increase in the solvency index, total return index and volatility index. Debt to equity declined from 0.09 to 0.05.

Sell 7/18/2016Upgraded
Invictus MD Strategies Corp. (IVITF) was upgraded to D- from E+ on 7/18/2016 due to a significant increase in the solvency index, efficiency index and volatility index.

Sell 7/1/2016Downgrade
Invictus MD Strategies Corp. (IVITF) was downgraded to E+ from D- on 7/1/2016 due to a significant decline in the solvency index, volatility index and efficiency index.

Sell 3/7/2016None
Invictus MD Strategies Corp. (IVITF) was downgraded to D- from U on 03/07/2016.